Ro
Ro
Digital health

Health technology

Business Highlights

Ro is a telehealth company that operates digital health clinics for men’s and women’s health, along with smoking cessation.

Ro is the healthcare technology company building a patient-centric healthcare system. Ro’s vertically integrated primary care platform powers a personalized, end-to-end healthcare experience from diagnosis, to delivery of medication, to ongoing care. 

With a nationwide provider network, in-home care API, and proprietary pharmacy distribution centers, Ro seamlessly connects telehealth, diagnostics, and pharmacy services to provide high-quality, affordable healthcare without the need for insurance.

6M digital healthcare visits, 46M patient touchpoints, 98% of care deserts served across the USA.

High-quality healthcare in minutes not days – No more taking time off from work. Ro delivers medication directly to the patient doorstep, provides in-home lab testing and nurse visits, and offers upfront, transparent pricing on all products and services.

Diagnosis to delivery – Ro’s platform is the only one that connects a nationwide network of providers with a nationwide pharmacy to deliver personalized treatment directly to your door.  This enables physicians, nurses, and pharmacists practicing on Ro’s platform to seamlessly track your journey with Ro, and facilitates frictionless care coordination between providers to provide you high-quality care from diagnosis to the delivery of medication, to ongoing care.

Digital Health Clinics

Connects a Nationwide Network of Providers

High-quality Healthcare in Minutes Not Days

Vertically Integrated Primary Care Platform

Key Information

PrimaryMarkets has sellers of this Unicorn Stock.

Minimum traction size – US$250,000.

All buyers must be Sophisticated/Accredited/Wholesale/Institutional Investors.

If interested please contact [email protected].

Financials

Total Funding (as of June 2021) – US$876.1M

Last funding round (March 2021) – US$500M (Series D)

Enterprise Value US$5.08B

Announcements

June 2021

Ro Press Release

Read more

May 2021

Ro Press Release

Read more

Team

Zachariah Reitano

Co-Founder and CEO

Saman Rahmanian

Co-Founder, Chief Product Officer

Rob Schutz

Co-Founder, Chief Growth Officer

Alexis Ohanian

Chloe Pi

Chief of Staff

Todd Levy

CTO

Daniel Wilcox

Director of Member Care

Sri Ray

Astronaut

Joycelyn Elders, MD

U.S. Surgeon General (1993-1994)

Matthew E. Fink, MD, FAAN, FAHA, FANA

Professor and Chair, Department of Neurology and Associate Dean for Clinical Affairs at Weill Cornell Medicine & Neurologist-in-Chief at New York Presbyterian Hospital/Weill Cornell

Steven Lamm, MD

Medical Director of NYU Men’s Health Center

Connie Newman, MD

Adjunct Professor of Medicine at NYU School of Medicine

Michael Eisenberg, MD

Associate Professor of Urology, and by courtesy, Obstetrics and Gynecology at The Stanford University Medical Center

Fernando Martinez, MD, MS

Chief of Pulmonary Care at Weill-Cornell Medicine

Seth Cohen, MD, MPH

Assistant Professor of Urology and Obstetrics and Gynecology, Director of the Sexual Dysfunction Program at NYU Langone Health

James Kashanian, MD

Assistant Professor of Urology at Weill Cornell Medicine

Michael Reitano, MD

Roman Physician in Residence

Michael Perelman, Ph.D

Director of the Human Sexuality Program at NY Presbyterian Hospital

Chris Dixon, MD

Renowned Urology Expert

Claus Roehrborn, MD

Chair of the Department of Urology at the University of Texas Southwestern

image

WOTSO

Real estate

image

Water Licence

Utilities

image

VCU Carbon Credits

Industrials

image

Virtual Home Loan Marketplace

Diversified Financial Services

image

TOR Mining Capital Limited

Metals & Mining

image

Tyro Payments Limited (ASX.TYR)

Diversified Financial Services

image

Tin International (GER)

Metals & Mining

image

Sydney Outback

Consumer Services

image

AIRR Holdings Limited

Retail

image

Biocure Technology (CSE:CURE, OTCQB:BICTF)

Biotechnology

image

The Cheeky Panda

Paper & Forest Products

image

Verita HealthCare Group

Health

    Thank you for your enquiry.
    We will be in touch as soon as possible.